Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemathera in Idiopathic Aplastic Anemia
NCT00399971Phase 2Unknown
- Sponsor
- Shenzhen Zhongxing Yangfan Bio-Engineering Co Ltd
- Start
- Nov 2002
- Primary completion
- Jun 2009
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin alfa in idiopathic aplastic anemia, sponsored by Shenzhen Zhongxing Yangfan Bio-Engineering Co Ltd. Status: unknown.
02
Drugs
epoetin alfa
03
Conditions
idiopathic aplastic anemia
Beyond the preview
Go deeper on NCT00399971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00399971.